Pharmaceuticals in the Trade Related Aspects of the Intellectual Property Rights (TRIPS) Agreement of the World Trade Organization - A Briefing on Trips
(2000; 20 pages)
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Ver el documento1. What is WTO and what is the TRIPS Agreement?
Ver el documento2. What are the implications of the TRIPS Agreement on patents for pharmaceutical products?
Ver el documento3. How long are patented drugs protected by the TRIPS Agreement?
Ver el documento4. Does the TRIPS Agreement strengthen the monopoly patenting of processes?
Ver el documento5. What are the impacts of the TRIPS Agreement on prices and availability of pharmaceutical products?
Ver el documento6. What can Member States do to counteract the impact of TRIPS on drug prices?
Ver el documento7. The balance between the protection of intellectual property rights and public policy objectives
Ver el documento8. When will the TRIPS Agreement be applied?
Ver el documento9. What is WHO’s view and position on WTO/TRIPS Agreement?
Ver el documento10. What are the recommendations for Member States?
 

5. What are the impacts of the TRIPS Agreement on prices and availability of pharmaceutical products?

• Twenty years of monopoly on a pharmaceutical product will enable the patent holder to keep the price of the patented drugs high.

• Copies of the drugs under patent either produced locally or imported should be banned from the market.

• The generic equivalents would come onto the market only after the expiry of the patent of a patented drug. During this period of patent protection, there will be no cheaper alternatives.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013